Vizsgálati helyszín
Centro Hospitalar Universitário de Santo Antonio,E.P.E.
Porto, 4099-001, PortugáliaMég nincs intézményhez kötve
- 13futó vizsgálat
- 20lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 33 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis29 vizsgálat
- 2. fázis2 vizsgálat
- 2/3. fázis1 vizsgálat
- 4. fázis1 vizsgálat
- Állapot
- Lezárult19 vizsgálat
- Fut, nem toboroz9 vizsgálat
- Toboroz4 vizsgálat
- Visszavonták1 vizsgálat
- Fő szponzor
- AbbVie2 vizsgálat
- Aerovate Therapeutics Inc.2 vizsgálat
- Bayer2 vizsgálat
- Hoffmann-La Roche2 vizsgálat
- Sanofi2 vizsgálat
- és még 20
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Fut, nem toboroz
A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis
NCT06407934· 3. fázis· Sanofi· Forrás
Lezárult
Study of Oral Atogepant Tablets to Assess Safety and Efficacy in Adult Participants With Migraine
NCT06241313· 3. fázis· AbbVie· Forrás
Lezárult
A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS).
NCT05975905· 2. fázis· Keros Therapeutics Inc.· Forrás
Fut, nem toboroz
Phase 2 Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants with PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
2023-503428-24-00· 2. fázis· Glaxosmithkline Research & Development Limited· Forrás
Fut, nem toboroz
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
NCT06260163· 3. fázis· Janssen Research & Development, LLC· Forrás
Fut, nem toboroz
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease
NCT05970172· 3. fázis· Astellas Pharma Global Development, Inc.· Forrás
Lezárult
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
NCT05934526· 3. fázis· GB002, Inc.· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)
NCT06181435· 3. fázis· Sanofi· Forrás
Meghívásos bevonás
A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy
NCT05979441· 3. fázis· argenx· Forrás
Lezárult
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
NCT05958407· 3. fázis· LEO Pharma· Forrás
Lezárult
Initiation of ARNi and SGLT2i in Patients With HFrEF
NCT05989503· 4. fázis· Universidade do Porto· Forrás
Lezárult
A Study to Evaluate Efficacy, Safety and Tolerability in Antiretroviral Therapy (ART)-Experienced Participants of at Least 50 Years of Age Living With Human Immunodeficiency Virus (HIV) With Virologic Suppression Who Switch to DTG/3TC FDC From BIC/FTC/TAF
NCT05911360· 3. fázis· ViiV Healthcare· Forrás
Toboroz
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
NCT05716100· 3. fázis· Xenon Pharmaceuticals Inc.· Forrás
Lezárult
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial – Follow Up Long Term Extension (IMPAHCT-FUL)
NCT05557942· 3. fázis· Aerovate Therapeutics Inc.· Forrás
Lezárult
Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis
NCT04991935· 3. fázis· Celgene· Forrás
Lezárult
Inhaled Imatinib Pulmonary Arterial Hypertension Clinical Trial (IMPAHCT) or A Phase 2b/3, Randomized, Controlled, 24-week Dose Ranging and Confirmatory Study of AV-101 in Patients with PAH
NCT05036135· 2/3. fázis· Aerovate Therapeutics Inc.· Forrás
Fut, nem toboroz
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
NCT05196035· 3. fázis· Bayer· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy, Safety and Pharmacokinetics (PK) of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis (PPMS)
NCT04548999· 3. fázis· Hoffmann-La Roche· Forrás
Lezárult
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
NCT03626688· 3. fázis· United Therapeutics· Forrás
Lezárult
This is an Extension Study of the Roche P-trials to Investigate Safety and Effectiveness of Ocrelizumab in Participants With Multiple Sclerosis (MS)
NCT03599245· 3. fázis· Hoffmann-La Roche· Forrás
Hibát jelzek